{"owner": "ArrayExpress Uploader", "pop_total": 0, "id": 1841, "factors": [{"GSE5392GSM123252": {"DiseaseState": "male"}}, {"GSE5392GSM123252": {"DiseaseState": "male"}}, {"GSE5392GSM123252": {"DiseaseState": "male"}}, {"GSE5392GSM123258": {"DiseaseState": "female"}}, {"GSE5392GSM123258": {"DiseaseState": "female"}}, {"GSE5392GSM123258": {"DiseaseState": "female"}}, {"GSE5392GSM123252": {"DiseaseState": "male"}}, {"GSE5392GSM123252": {"DiseaseState": "male"}}, {"GSE5392GSM123252": {"DiseaseState": "male"}}, {"GSE5392GSM123258": {"DiseaseState": "female"}}, {"GSE5392GSM123252": {"DiseaseState": "male"}}, {"GSE5392GSM123258": {"DiseaseState": "female"}}, {"GSE5392GSM123258": {"DiseaseState": "female"}}, {"GSE5392GSM123258": {"DiseaseState": "female"}}, {"GSE5392GSM123258": {"DiseaseState": "female"}}, {"GSE5392GSM123252": {"DiseaseState": "male"}}, {"GSE5392GSM123252": {"DiseaseState": "male"}}, {"GSE5392GSM123258": {"DiseaseState": "female"}}, {"GSE5392GSM123252": {"DiseaseState": "male"}}, {"GSE5392GSM123252": {"DiseaseState": "male"}}, {"GSE5392GSM123252": {"DiseaseState": "male"}}], "ownerprofile_id": "arrayexpress_sid", "platform": 3, "summary_wrapped": "Bipolar affective disorder is a severe psychiatric disorder with a strong genetic component but unknown pathophysiology. We used...", "pubmed_id": 16894394, "geo_gse_id": "E-GEOD-5389", "owner_profile": "/profile/8773/arrayexpressuploader", "factor_count": 1, "sample_count": 21, "tags": ["bipolar disorder", "brain", "cortex", "disease", "orbitofrontal cortex"], "lastmodified": "Dec.12, 2014", "is_default": false, "geo_gds_id": "", "slug": "transcription-profiling-of-human-post-mortem-brain", "geo_id_plat": "E-GEOD-5389_A-AFFY-33", "name": "Transcription profiling of human post-mortem brain tissue (orbitofrontal cortex) from patients with bipolar disorder and matched healthy controls", "created": "Jun.20, 2014", "summary": "Bipolar affective disorder is a severe psychiatric disorder with a strong genetic component but unknown pathophysiology. We used microarray technology (Affymetrix HG-U133A GeneChips) to determine the expression of approximately 22 000 mRNA transcripts in post-mortem brain tissue (orbitofrontal cortex) from patients with bipolar disorder and matched healthy controls. Orbitofrontal cortex tissue from a cohort of 30 subjects was investigated and the final analysis included 10 bipolar and 11 control subjects. Differences between disease and control groups were identified using a rigorous statistical analysis with correction for confounding variables and multiple testing.", "source": "http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-5389", "species": "human", "sample_source": "http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-5389/samples/"}